Publication

Byline

Clinical Trial: Scapular Stabilization Versus Proprioceptive Neuromuscular Facilitation Technique in Scapular Dyskinesis

U.S., Sept. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07841652) titled 'Scapular Stabilization Versus Proprioceptive Neuromuscular Facilitation Technique in Scapu... और पढ़ें


Clinical Trial: AI-based Prognostic Factors Identification in Early-stage Invasive Lobular Breast Carcinoma

U.S., Sept. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07842055) titled 'AI-based Prognostic Factors Identification in Early-stage Invasive Lobular Breast Carcinom... और पढ़ें


Clinical Trial: Suzetrigine Versus Standard Analgesia After Skin Cancer Surgery

U.S., Sept. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07843134) titled 'Suzetrigine Versus Standard Analgesia After Skin Cancer Surgery' on Sept. 21. Brief Summa... और पढ़ें


Department of Chemicals and Petrochemicals Gears Up for Special Campaign 6.0 with Focus on E-Waste Disposal, Cleanliness and Workplace Efficiency

Bhubaneswar, Sept. 26 -- The Department of Chemicals and Petrochemicals (DCPC), Ministry of Chemicals and Fertilizers, is gearing up for Special Campaign 6.0, scheduled to be undertaken from 2nd to 31... और पढ़ें


Manchester City chairman Khaldoon Al Mubarak reassures fans after 114 Premier League FFP charges verdict

New Delhi, Sept. 26 -- Manchester City's chairman has told supporters the club's stance has not shifted a day after reports that an independent commission found the champions guilty on 114 of 115 Prem... और पढ़ें


Singapore Clinical Trial: A Phase 3, Randomized, Open-Label Study of Rinzimetostat (ORIC-944) in Combination with Darolutamide Compared with ARPI or Docetaxel in Patients with Metastatic Castration Resistant Prostate Cancer Previously Treated with Abiraterone Acetate (Himalayas-1)

Singapore, Sept. 26 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Open-Label Study of Rinzimetostat (ORIC-944) in Combination with Darolutam... और पढ़ें


Singapore Clinical Trial: An Interventional Phase 3, Open Label, Randomized Study To Evaluate Efficacy And Safety of PF-08634404 in Combination With Chemotherapy Versus Pembrolizumab in Combination With Chemotherapy in Adult Participants With Advanced or Recurrent Mismatch Repair (MMR) Proficient Endometrial Cancer

Singapore, Sept. 26 -- The Health Sciences Authority received information related to the study titled 'An Interventional Phase 3, Open Label, Randomized Study To Evaluate Efficacy And Safety of PF-086... और पढ़ें


Singapore Clinical Trial: A Randomized, Double-blind, Phase 3 Study of Pembrolizumab + Pemetrexed + Platinum Chemotherapy With or Without Zoldonrasib (RMC-9805) as First Line Treatment in Patients With Metastatic Non-squamous RAS G12D-Mutated Non-small Cell Lung Cancer (RASolve 308)

Singapore, Sept. 26 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Double-blind, Phase 3 Study of Pembrolizumab + Pemetrexed + Platinum Chemotherapy W... और पढ़ें


Singapore Clinical Trial: A Phase 3, Randomized, Open-Label Study of Zoldonrasib (RMC-9805) Plus Daraxonrasib (RMC-6236) Versus Gemcitabine and Nab-Paclitaxel as First-Line Treatment in Patients With Metastatic KRAS G12D-Mutated Pancreatic Adenocarcinoma (RASolute 309)

Singapore, Sept. 26 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Open-Label Study of Zoldonrasib (RMC-9805) Plus Daraxonrasib (RMC-6236) Ve... और पढ़ें


Singapore Clinical Trial: A Phase 3, two-part, double-blind, randomized, placebo-controlled study to investigate the safety and efficacy of efimosfermin alfa injection in adult participants with compensated cirrhosis (stage F4 fibrosis) due to metabolic dysfunction-associated steatohepatitis (NEBULA-2)

Singapore, Sept. 26 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, two-part, double-blind, randomized, placebo-controlled study to investigate the safety... और पढ़ें